Abstract: This account deals with an overview of our recent progress toward the development of molecular catalysts for the reduction in polar functionalities with molecular hydrogen (H 2 ). An emphasis is placed on the newly designed Cp*Ru(PN) complexes, which have been identified as efficient catalysts for the hydrogenation of imides. The structural modification of the complex enhances the catalytic performance and allows efficient access to various chiral synthetic intermediates.
INTRODUCTION
Hydrogen (H 2 ) is the simplest molecule, and this readily available clean recourse could prove invaluable in synthetically useful applications if a highly efficient tailor-made catalyst were to become available [1] . In 2001, we found that H 2 bound to the 16-electron Cp*Ru{Me 2 N(CH 2 ) 2 NH 2 } + fragment (1) readily forms a hydrogen-bonding network with basic 2-propanol to result in the formation of coordinatively saturated 18-electron Cp*RuH{Me 2 N(CH 2 ) 2 NH 2 } (2) as illustrated in Scheme 1 [2] . This solvent-assisted heterolytic H 2 cleavage effectively builds up electrophilic NH and nucleophilic RuH in the complex. Importantly, thus generated electronically opposite two hydrogen atoms do not collapse into H 2 but transfer to ketones with polar C=O bonds as a proton and hydride to release alcohols irreversibly, while the Ru counterpart abstracts the proton in alcoholic media to regenerate 1. These findings led to the development of asymmetric hydrogenation of ketones through the chiral modification of a diamine ligand, which shows an excellent catalytic performance in terms of chemo-and stereoselectivity. The cooperative reactivity of the electrophilic NH and nucleophilic RuH inspired us to aim at developing new molecular catalysts for the straightforward hydrogenation of more polar organic molecules such as carboxylic acids and their derivatives, whose reduction still relies mostly on the stoichiometric use of metal hydride reagents such as LiAlH 4 .
PREPARATION OF Cp*Ru COMPLEXES WITH A PROTIC CHELATING AMINE LIGAND
The study was initiated by the preparation of a series of late transition-metal Cp* complexes with chelating protic amine (LN) ligands (Fig. 1 ) in order to gain an insight into the effective catalyst design for the hydrogenation of more polar functionalities [3] . Although the catalytic potential of these new complexes has not yet been fully exploited, the most interesting results obtained thus far are those of the chemistry of Cp*Ru complexes.
The coordinatively saturated Cp*RuCl(LN) complexes (3) were obtained by mixing tetranuclear (Cp*RuCl) 4 with (tert-amino)alkylamine or pyridylamine (NN) compounds [2a] . Alternatively, the treatment of mononuclear Cp*RuCl(isoprene) complex with (diphenylphosphino)alkylamine (PN) compounds efficiently gave similar complexes [3a] (Scheme 2). Figure 2 shows the molecular structures of typical Cp*RuCl(LN) complexes; the left one (3d) bears a chiral NN ligand [2a] , and the right one (3e) has a chiral PN ligand [3a,5b,6] . Both complexes have unusually long Ru-Cl bonds, possibly due to the electron-donating property of protic amine ligands. Importantly, however, the bond length in 3d is slightly longer than 3e. This could be attributable to the difference in the electron density of the metal centers having tertiary amine and tertiary phosphine ligands.
Scheme 2
Next, to obtain further evidence for the electronic properties of these complexes, we prepared a series of cationic Cp*Ru complexes bearing an LN ligand [3b] . As shown in Scheme 3, the reaction of [Cp*Ru(MeCN)(LN)]OTf (4) in high yields. The acetonitrile ligand in these new complexes was substitutionally labile and readily replaced by CO, isocyanide, and phosphine to give new cationic complexes (5-7). 13 C{ 1 H} NMR spectroscopy of the acetonitrile complexes 4a-c and IR measurement of the carbonyl complexes 5a-c have revealed the relatively weaker σ-donating and stronger π-accepting abilities of the phosphino group as compared to dimethylamino or pyridine in the Cp*Ru complexes. Thus, the resonances of the ring carbon of Cp* in the NN complexes 4a and 4b appear in higher fields than that of the PN complex 4c. Additionally, the carbonyl stretching frequencies of the NN complexes 5a and 5b are observed at 1931 and 1938 cm -1 , while that of the PN complex 5c is recorded at a higher wavenumber of 1948 cm -1 . These results indicate that the electron density of a series of Cp*Ru(PN) complexes should be lower and more Lewis acidic than that of the Cp*Ru(NN) complexes. In other words, the Brønsted acidity of the ligated NH 2 group in the PN complexes should be higher than that in the Cp*Ru(NN) complexes. This rationale is consistent with the aforementioned difference between the Ru-Cl bond lengths of 3d and 3e.
CATALYTIC PERFORMANCE OF Cp*RuCl(LN) COMPLEXES
The electronic properties of the Cp*Ru(LN) complexes are closely correlated with their catalytic performance in the hydrogenation of the polar functionalities. On treatment with an equimolar amount of alkaline base in 2-propanol, the PN complex 3c efficiently promotes the catalytic hydrogenation of epoxides [4] and imides [6] in addition to ketones or aldehydes, whereas the NN complexes 3a and 3b are only effective for the ketones or aldehydes. The wider range of polar functionalities reducible by 3c indicates that the possibly active species, Cp*RuH(PN), exerts a stronger electrophilic activation in the transition state than the corresponding Cp*Ru(NN) congeners. Ligand screening with N-benzylphthalimide as a model substrate reveals that the PN ligand with the ethylene linkage displays the highest rate enhancement among various examined PN ligands, giving the N-benzyl o-hydroxymethylbenzamide exclusively. As summarized in Scheme 4, the best catalyst system of 3c and the base promotes the chemoselective hydrogenation of a wide array of imides in 2-propanol to give the corresponding hydroxyamides. Due to high chemoselectivity, this hydrogenation method is applicable to the deprotection of primary amines from N-phthaloyl-protected amino acid ester derivatives. For example, N-phthaloyl-L-Phe methyl ester undergoes hydrogenation to generate N-(o-hydroxymethylbenzoyl)-L-Phe methyl ester, whose acid-promoted cyclization quantitatively liberates the HCl salt of L-Phe methyl ester with the concomitant formation of phthalide. Notably, no measurable loss of the optical purity of the corresponding amino acid derivative was observed in this process (Scheme 5).
A chiral catalyst with an optically active PN ligand promotes the asymmetric hydrogenation of prochiral imides via desymmetrization. Notably, the substituents on nitrogen in the cyclic imides significantly influence the enantioselectivity. For example, the chiral catalyst 3e favors N-aromatic groups over N-aliphatic groups among 4-(p-fluorophenyl)glutarimides with different substituents on nitrogen; the N-3,4-(OCH 2 O)C 6 H 3 group resulted in the highest enantioselectivity (Scheme 6).
A variety of sym-glutarimides with the N-3,4-(OCH 2 O)C 6 H 3 group undergo highly enantioselective hydrogenation to furnish the corresponding hydroxyamides in high enantioselectivities (Scheme 7). It should be noted that sym-glutaric acid derivatives with an aryl substituent at the β-position of the carbonyl group were easily prepared from a cis-trans mixture of diethyl glutaconate by the Rh-catalyzed addition of arylboronic acid as a key step. In addition, 2,4-substituted bicyclic sym-glutaric acid derivatives were also readily prepared by the Diels-Alder reactions with cyclopentadiene and the subsequent oxidative transformations of olefinic moieties. Furthermore, our hydrogenation method would provide highly functionalized chiral hydroxyamides, which require otherwise tedious multi-step synthesis.
The bromination and base-induced cyclization efficiently converted the chiral product (>99 % ee) derived from 4-(p-fluorophenyl)glutarimide to the corresponding chiral lactam, whose N-3,4-(OCH 2 O)C 6 H 3 group was readily removed by the oxidative cleavage with CAN. The product serves as a versatile intermediate for physiologically active chiral compounds including the antidepressant paroxetine (Scheme 8). This result demonstrates the synthetic potential of our present hydrogenation method.
